SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-002620
Filing Date
2024-01-31
Accepted
2024-01-31 09:00:20
Documents
17
Period of Report
2024-01-31
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20240123_8k.htm   iXBRL 8-K 33783
2 EXHIBIT 3.1 ex_618362.htm EX-3.1 10558
3 EXHIBIT 99.1 ex_620718.htm EX-99.1 13725
  Complete submission text file 0001437749-24-002620.txt   207322

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20240131.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20240131_def.xml EX-101.DEF 12187
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20240131_lab.xml EX-101.LAB 16396
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20240131_pre.xml EX-101.PRE 12457
18 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20240123_8k_htm.xml XML 3031
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 24580765
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)